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A B S T R A C T
Many idiopathic epilepsies have been shown to be caused by ion channel dysfunction. Channelopathies
also cause the long QT syndrome (LQTS) which is associated with syncopes and sudden cardiac death. It
has been postulated that the same channelopathy may be associated with both epilepsy and LQTS. We
report a patient with idiopathic epilepsywho died in sudden unexpected death in epilepsy (SUDEP) at the
age of 25. A post mortem DNA sequencing of the LQTS-associated genes revealed a novel missense
mutation in the SCN5A gene coding for the cardiac sodium channel, voltage gated, type V, alpha subunit.
The possibility that the mutation may explain both the epilepsy and the sudden death is discussed.
However, the patient was treated with lamotrigine which may interfere with cardiac ion channels and
may also have played a part in inducing a terminal cardiac arrhythmia.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Many idiopathic epilepsies have been connected to channelo-
pathies.1 Likewise the congenital long QT syndrome (LQTS) which
is associated with syncope and sudden cardiac death has been
shown to be caused by ion channel dysfunction.2 Most of the more
than 400 different mutations that have been found to cause LQTS
involve the potassium or sodium channel.3
It has been postulated that the same channelopathy may be
associated with both familial long QT syndrome and epilepsy,4 but
so far there is little clinical evidence that connects cardiac ion
channel dysfunction with epilepsy.
Recently, we reported four SUDEP victims with idiopathic
epilepsy that were all young females treated with lamotrigine in
monotherapy.5 The deaths occurred during the 10 years period
1995–2005, and after the common denominators were recognized
our hypothesis was that a genetic predisposition to cardiac
arrhythmia may have played a part to their deaths. We therefore
performed a post mortem analysis of the LQTS genes in these four
patients. In three of the victims no abnormalities were found. In
one (case one in our previous report) a novel mutation was
detected.* Corresponding author. Tel.: +47 51518447; fax: +47 51519916.
E-mail address: auda@sus.no (D. Aurlien).
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doi:10.1016/j.seizure.2008.07.0082. Patient and methods
This previously healthy woman had her ﬁrst seizure at the age
of 17 years. The seizures started with a feeling of de´ja` vu, followed
by a feeling of fear and a sensation down her chest which she
described as being similar to an electrical current. She also felt
ﬂushed and had palpitations. The seizures lasted only a few
seconds. Sometimes the patient’s consciousness was reduced
during these episodes. She also had generalized convulsive
seizures and a few myoclonias.
After she was diagnosed with epilepsy at the age of 24 she was
initially treated with carbamazepine (CBZ) in monotherapy.
Because of insufﬁcient effect the treatment was switched to
valproate (VPA) which also had an unsatisfactory effect. After
lamotrigine (LTG) was added to VPA 7 months ante mortem the
seizure frequency was reduced, but the patient experienced side
effects like hand tremor and tiredness. VPAwas then tapered down
and withdrawn 4 weeks ante mortem. At the time of SUDEP she
was treated with lamotrigine 100 mg/day in monotherapy with no
concurrent medication.
Her standard EEG showed frequent bursts of bilateral synchro-
nous spikes followed by slow waves with side shift dominance
with duration up to 2–3 s. A concurrent cardiac abnormality was
not suspected ante mortem and unfortunately, an ECG was not
conducted. The cerebral MRI was normal.
At the age of 25 she was found dead lying prone in her bed.
Diagnosis after autopsy was SUDEP.5vier Ltd. All rights reserved.
Fig. 1. Identiﬁcation of mutation R523C in the SCN5A gene by DNA sequencing. The
ﬁgure shows the DNA sequence of the anti-sense strand of nucleotides 1548–1585
of the SCN5A gene in a normal subject (upper panel) and in the SUDEP victim (lower
panel). Above the electropherograms are shown the nucleotide compositions
(A = adenosine; C = cytosine; G = guanosine; T = thymidine). Heterozygosity for an
adenosine at nucleotide 1567 in the SUDEP victim is indicated by the arrow. This
mutation changes codon 523 from CGT (arginine, R) to TGT (cysteine, C).
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sequences of the LQTS-associated genes KCNQ1, HERG, SCN5A,
minK and MiRP1 was performed as described by Berge et al.6 to
study whether the patient actually had a channelopathy.
3. Results
The molecular genetic analyses revealed that the patient was
heterozygous for the novel missense mutation R523C in exon 12 of
the SCN5A gene (accession number XP_001131636) coding for the
cardiac sodiumchannel, voltage gated, typeV, alpha subunit (Fig. 1).
This mutation was not identiﬁed in 315 unrelated Norwegian
subjects referred for genetic testing with respect to LQTS. The
mutation changes codon 523 fromarginine to cysteine. Arginine is a
polar and strongly basic residue, whereas cysteine is polar and
neutral. Thus, there will be a change in charge. The amino acid
substitution is located in a highly conserved region of the protein. It
was predicted to be pathogenic by the use of the prediction program
PolyPhen which is a bioinformatics tool that takes several
parameters into account—like changes in charge of the amino acid
substitution, sequence homology between species and effect on
three-dimensional structure. More detailed information about
Polyphen can be found on http://coot.embl.de/PolyPhen/
4. Discussion
In a recent review Nashef et al.7 discussed a possible genetic
predisposition to cardiac arrhythmia in SUDEP victims. However,
the authors concluded that bridging evidence between cardiac
inherited gene determinants and SUDEP is lacking.
The novel mutation we have detected is to our knowledge the
ﬁrst example described of a LQTS mutation in a SUDEP victim.
Although the lack of an ECG precludes a ﬁrm clinical diagnosis of
LQTS it is difﬁcult to believe that the mutation is just a coincidence
with no relation to the SUDEP.
Mutations in the SCN5A gene is associated with Brugada
syndrome and the congenital LQTS type 3.8 In addition to sudden
cardiac death suchmutationsmay cause syncopes and seizures.9 Inthe literature there are several reports on patients with seizures
that after a previous incorrect diagnosis of epilepsy eventually
turned out to represent convulsive syncopes due to LQTS.9–11
We are not aware of convincing clinical evidence that
mutations in the SCN5A gene may cause genuine epilepsy.
However, the SCN5A gene has been shown to be selectively
expressed in limbic regions of rat brain,4 and the authors suggest
that arrhythmias of heart and brain may be related and implicate
SCN5A in some forms of primary inherited epilepsy. This may be
relevant in explaining the seizures of our patient since they started
with a de´ja` vu which is associated with the limbic system.12
Based on the ictal semiology the clinical episodes were
considered to represent simple, complex partial and generalized
tonic clonic epileptic seizures. However, the classiﬁcation of the
epilepsy syndrome was not unequivocal since the patient in
addition to partial seizures also reported myoclonias and had an
EEG with bilateral synchronous epileptogenic activity indicating
generalized seizures.
Although the diagnosis of epilepsy seemed obvious with the
epileptogenic activity in the EEG one might ask whether the
diagnosisofepilepsywas incorrect andwhether theclinicalepisodes
could be explained as episodes of cardiac arrhythmias and syncopes
which sometimes were convulsive. When the EEG was done the
patient was treated with the tricyclic antidepressant clomipramine
10 mg t.i.d. because the symptomswere initially considered to be of
psychogenic origin. It has been reported that high doses of tricyclic
antidepressants may elicit epileptogenic activity in the EEG.13
However, thedrugdosewasmoderateand theepileptogenic activity
very prominent and we therefore ﬁnd this explanation unlikely.
Cardiac arrhythmia and respiratory arrest have been regarded
as the two most probable pathophysiological mechanisms in
SUDEP.14 However, cardiac arrhythmias may result from a
combination of predisposing factors and in epilepsy an arrhythmia
may be more likely in a susceptible individual in the presence of
apnoe/hypoxia.7 SUDEP may therefore not necessarily be caused
by a single factor but rather a combination of factors causing the
terminal event. The cardiac SCN5Amutation that we have detected
may have been of major importance in explaining the death of this
young woman. Nevertheless a terminal epileptic seizure as well as
a possible arrhythmogenic effect from the drugmay also have been
involved. LTG exerts its effect through blockade of sodium
channels which has been claimed to cause widening of the QRS
complex and right-axis deviation in the ECG.15 A blockade of the
cardiac potassium channel Ikr may also have played a part.16
5. Conclusion
The new SCN5A mutation that we have detected may support
the notion that an ion channel mutation may be expressed both in
brain and heart and give rise to both a tendency to epileptic
seizures and a predisposition to cardiac arrhythmias. However, we
have so far no evidence for a causative relationship between the
mutation and the epilepsy in this patient.
More research is needed to revealwhether certain patientswith
epilepsy are genetically predisposed to cardiac arrhythmias due to
expression of the samemutation in both brain and heart. This may
be of particular importance in the choice of antiepileptic treatment
to avoid drugs that may increase the tendency to potentially life
threatening cardiac arrhythmias.
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